DE2723186A1 - Isoindol-derivate - Google Patents

Isoindol-derivate

Info

Publication number
DE2723186A1
DE2723186A1 DE19772723186 DE2723186A DE2723186A1 DE 2723186 A1 DE2723186 A1 DE 2723186A1 DE 19772723186 DE19772723186 DE 19772723186 DE 2723186 A DE2723186 A DE 2723186A DE 2723186 A1 DE2723186 A1 DE 2723186A1
Authority
DE
Germany
Prior art keywords
hydrogen
chloro
carboxylic acid
phenylisoindole
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772723186
Other languages
German (de)
English (en)
Inventor
Roland Prof Dr Jaunin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2723186A1 publication Critical patent/DE2723186A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DE19772723186 1976-05-21 1977-05-23 Isoindol-derivate Withdrawn DE2723186A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH645476 1976-05-21
CH287677 1977-03-08
US05/789,905 US4122265A (en) 1976-05-21 1977-04-22 Derivatives of 3-phenylisoindole-1-carboxylic acid
US05/928,135 US4167632A (en) 1976-05-21 1978-07-26 Derivatives of 3-phenylisoindole-1-carboxylic acid

Publications (1)

Publication Number Publication Date
DE2723186A1 true DE2723186A1 (de) 1977-12-08

Family

ID=27428523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772723186 Withdrawn DE2723186A1 (de) 1976-05-21 1977-05-23 Isoindol-derivate

Country Status (9)

Country Link
US (2) US4122265A (enExample)
JP (1) JPS52142059A (enExample)
AU (1) AU510035B2 (enExample)
BE (1) BE854780A (enExample)
CA (1) CA1079288A (enExample)
DE (1) DE2723186A1 (enExample)
FR (1) FR2355823A1 (enExample)
GB (1) GB1568259A (enExample)
NL (1) NL7705590A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263504B (enExample) * 1991-10-03 1995-11-21 Pfizer
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
AU2019272778B2 (en) 2018-05-22 2024-10-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
CA3099791A1 (en) 2018-05-29 2019-12-05 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
US12077512B2 (en) * 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48441A (en) * 1974-11-28 1978-09-29 Sparamedica Ag Isoindole derivatives their manufacture and pharmaceutical compositions containing them
US4077978A (en) * 1974-11-28 1978-03-07 Hoffmann-La Roche Inc. Isoindole derivatives

Also Published As

Publication number Publication date
FR2355823A1 (fr) 1978-01-20
FR2355823B1 (enExample) 1981-01-09
US4167632A (en) 1979-09-11
AU2516177A (en) 1978-11-23
GB1568259A (en) 1980-05-29
NL7705590A (nl) 1977-11-23
CA1079288A (en) 1980-06-10
JPS52142059A (en) 1977-11-26
US4122265A (en) 1978-10-24
AU510035B2 (en) 1980-06-05
BE854780A (fr) 1977-11-18

Similar Documents

Publication Publication Date Title
CH399465A (de) Verfahren zur Herstellung von Indolyloverbindungen
DE60104776T2 (de) Diphenylharnstoffderivate und deren Verwendung als alpha2/5-HT2c Antagonisten
DE2017255A1 (de) 1-substituierte-3-Pheny!pyrrolidine und Verfahren zu deren Herstellung
DE3336024A1 (de) 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE2302717A1 (de) Heterocyclische verbindungen
DE1545935A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
DE2336130A1 (de) Tricyclische verbindungen
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
DE2539131C2 (de) 8-Chlor-1-[(dimethylamino)methyl]-6-phenyl-4H-imidazo[1,2-a][1,4]benzodiazepinesowie ein Verfahren zu deren Herstellung
DE2723186A1 (de) Isoindol-derivate
DE1670305C3 (de) 5-Phenyl-2,4-dioxo-1,2,3,4-tetrahydro-3H-1,5-benzodiazepine und Verfahren zu ihrer Herstellung
CH626892A5 (enExample)
DE2553595A1 (de) Isoindol-derivate
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2754112A1 (de) 1,4-benzodiazepinderivate, ihre salze und diese verbindungen enthaltende arzneipraeparate
DE1543666A1 (de) Verfahren zur Herstellung von Diaminen
DE2332398A1 (de) 2-carbalkoxy-amino-benzimidazol-5(6)phenylaether, ihre herstellung und verwendung in mitteln gegen helminthen
DE1905353B2 (de) 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen
EP0126480B1 (de) Substituierte Isochinolinderivate, Verfahren zu deren Herstellung sowie Arzneimittel enthaltend diese Verbindungen
DE2000775A1 (de) Substituierte 1,2,3,4-Tetrahydrobenzothieno-[2,3-c]-pyridinderivate und Verfahren zu deren Herstellung
EP0008421A2 (de) Benzodiazepin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1770206A1 (de) Verfahren zur Herstellung von Benzodiazepinderivaten
DE2005508A1 (de) Benzodiazepin-Derivate
DE2461137A1 (de) Tricyclische verbindungen
DE1445873A1 (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten

Legal Events

Date Code Title Description
OB Request for examination as to novelty
OC Search report available
8139 Disposal/non-payment of the annual fee